Neurosurgical gram-negative bacillary ventriculitis and meningitis: A retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases

Clinical Infectious Diseases

Volumn 52, Issue 11, 2011, Pages 1310-1316

  Tängdén, Thomas ^a   Enblad, Per ^b   Ullberg, Måns ^b   Sjölin, Jan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; GENTAMICIN; IMIPENEM; MEROPENEM; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADULT; AGED; ARTICLE; BRAIN VENTRICULITIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DRUG EFFICACY; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HUMAN; MEDICAL RECORD; MENINGITIS; MORTALITY; NEUROSURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CEREBRAL VENTRICULITIS; CEREBROSPINAL FLUID; DRUG THERAPY, COMBINATION; GENTAMICINS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFUSIONS, INTRAVENTRICULAR; MENINGITIS, BACTERIAL; MIDDLE AGED; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; SWEDEN; THIENAMYCINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79957478838     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir197     Document Type: Article

References (27)

1. Berk SL, McCabe WR. Meningitis caused by gram-negative bacilli. Ann Intern Med 1980; 93:253-260. (Pubitemid 10044707)
2. Blomstedt GC. Post-operative aseptic meningitis. Acta Neurochir (Wien) 1987; 89:112-116. (Pubitemid 18007899)
3. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterialmeningitis. Clin Infect Dis 2004; 39:1267-1284.
4. Federico G, Tumbarello M, Spanu T et al. Risk factors and prognostic indicators of bacterial meningitis in a cohort of 3580 postneurosurgical patients. Scand J Infect Dis 2001; 33:533-537. (Pubitemid 32755347)
5. Briggs S, Ellis-Pegler R, Raymond N, Thomas M, Wilkinson L. Gramnegative bacillary meningitis after cranial surgery or trauma in adults. Scand J Infect Dis 2004; 36:165-173. (Pubitemid 38618376)
6. Mancebo J, Domingo P, Blanch L, Coll P, Net A, Nolla J. Postneurosurgical and spontaneous gram-negative bacillary meningitis in adults. Scand J Infect Dis 1986; 18:533-538. (Pubitemid 17197949)
7. Lu CH, Chang WN, Chuang YC, Chang HW. The prognostic factors of adult gram-negative bacillary meningitis. J Hosp Infect 1998; 40:27-34.
8. Mombelli G, Klastersky J, Coppens L, Daneau D, Nubourgh Y. Gramnegative bacillary meningitis in neurosurgical patients. J Neurosurg 1983; 59:634-641. (Pubitemid 13008562)
9. Parodi S, Lechner A, Osih R, Vespa P, Pegues D. Nosocomial enterobacter meningitis: Risk factors, management, and treatment outcomes. Clin Infect Dis 2003; 37:159-166. (Pubitemid 36930344)
10. O'Neill E, Humphreys H, Phillips J, Smyth EG. Third-generation cephalosporin resistance among gram-negative bacilli causing meningitis in neurosurgical patients: Significant challenges in ensuring effective antibiotic therapy. J Antimicrob Chemother 2006; 57:356-359. (Pubitemid 43160184)
11. Cherubin CE, Corrado ML, Nair SR, Gombert ME, Landesman S, Humbert G. Treatment of gram-negative bacillary meningitis: Role of the new cephalosporin antibiotics. Rev Infect Dis 1982; 4:S453-S464.
12. Talon D, Bailly P, Bertrand X, Thouverez M, Mulin B. Clinical and molecular epidemiology of chromosome-mediated resistance to thirdgeneration cephalosporins in enterobacter isolates in eastern France. Clin Microbiol Infect 2000; 6:376-384. (Pubitemid 34960238)
13. Lu CH, Chang WN, Chuang YC. Resistance to third-generation cephalosporins in adult gram-negative bacillary meningitis. Infection 1999; 27:208-211. (Pubitemid 29257747)
14. Ventura G, Tumbarello M, Tacconelli E, Cauda R, Lucia MB. Gramnegative bacillary meningitis in adults. J Chemother 1995; 7(Suppl. 4): 177-179.
15. LeFrock JL, Smith BR, Molavi A. Gram-negative bacillary meningitis. Med Clin North Am 1985; 69:243-256. (Pubitemid 15042671)
16. Lutsar I, McCracken GH Jr, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 1998; 27:1117-1127. quiz 28-9.
17. Wen DY, Bottini AG, Hall WA, Haines SJ. Infections in neurologic surgery. The intraventricular use of antibiotics. Neurosurg Clin N Am 1992; 3:343-354.
18. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21-28. (Pubitemid 23011467)
19. Leib SL, Boscacci R, Gratzl O, Zimmerli W. Predictive value of cerebrospinal fluid (csf) lactate level versus csf/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis 1999; 29:69-74. (Pubitemid 29336804)
20. The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. Br J Neurosurg 2000; 14:7-12.
21. McCracken GH Jr, Mize SG, Threlkeld N. Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet 1980; 1:787-791. (Pubitemid 10134726)
22. Vogelman B, Craig WA. Kinetics of antimicrobial activity. J Pediatr 1986; 108(Pt 2):835-840. (Pubitemid 16063283)
23. Ahmed A, Paris MM, Trujillo M, et al. Once-daily gentamicin therapy for experimental Escherichia coli meningitis. Antimicrob Agents Chemother 1997; 41:49-53. (Pubitemid 26428131)
24. Ferrara A, Grassi G, Grassi FA, Piccioni PD, Gialdroni Grassi G. Bactericidal activity of meropenem and interactions with other antibiotics. J Antimicrob Chemother 1989; 24(Suppl. A):239-250. (Pubitemid 19248745)
25. Mimoz O, Jacolot A, Padoin C, et al. Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo. J Antimicrob Chemother 1997; 39:363-369. (Pubitemid 27153796)
26. Mohr JF 3rd. Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections. Clin Infect Dis 2008; 47(Suppl. 1):S41-S51.
27. Nau R, Lassek C, Kinzig-Schippers M, Thiel A, Prange HW, Sorgel F. Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy. Antimicrob Agents Chemother 1998; 42:2012-2016. (Pubitemid 28363085)